Holstebro Hospital
Holstebro, 7500, Denmark
NCT Number: NCT00438503
The purposes are 1. to measure the effect of dialysis with glucose in dialysis water on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and 2. to analyse the relationship between the changes in blood pressure and changes in vasoactive hormones
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Holstebro, 7500, Denmark
The relationship between blood pressure during dialysis treatment and vasoactive hormones are studied. This includes measurements of plasma concentration of glucose, plasma concentrations og insulin, glucagon, growth hormone, renin, angiotensin II, endothelin
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Regional Hospital Holstebro
Other
Effect of Glucose in Dialysis Water in Diabetics With Chronic Renal Failure on Blood Pressure, Pulse Rate, Plasma Glucose, Plasma Concentrations of Insulin, Growth Hormone, Renin, Angiotensin II, Endothelin and Body Temperature
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06814132
Chronic Disease, Disease Attributes
Orlando, Florida, United States
View Trial DetailsNCT03904836
Chronic Disease, Disease Attributes
Montreal, Quebec, Canada
View Trial DetailsNCT01875523
Chronic Disease, Disease Attributes
Grünstadt, Germany
View Trial DetailsNCT00438295
Chronic Disease, Disease Attributes
Holstebro, Denmark
View Trial Details